Quarterly report on the progress of segregation camps and medical treatment of sleeping sickness in Uganda. For the quarter December 1st, 1907-February 29th, 1908 / A. C. H. Gray. With an introduction by A. D. P. Hodges.

  • Hodges, A. D. P.
Date:
1908
Catalogue details

Licence: In copyright

Credit: Quarterly report on the progress of segregation camps and medical treatment of sleeping sickness in Uganda. For the quarter December 1st, 1907-February 29th, 1908 / A. C. H. Gray. With an introduction by A. D. P. Hodges. Source: Wellcome Collection.

Provider: This material has been provided by London School of Hygiene & Tropical Medicine Library & Archives Service. The original may be consulted at London School of Hygiene & Tropical Medicine Library & Archives Service.

    29/40 (page 27)
    caused frequent salivation of a temporary character, not exceeding three to five da}'’S.” As can be seen from the tables (XXI-XXVI), Drs. Goodliffe andBayon have so far been very successful with this treatment at Sesse. It must be remembered, however, that it is only two months since this treatment was started on Sesse. There is also another point about treatment on Sesse. As will be seen from the tables comparing the results of Atoxyl treatment alone at the various camps since December 1, 1907 (table Xo. XX), the Sesse death- rate is very mucli lower than at other camps. Now the methods of Atoxyl treatment since December 1, 1907, have practically been the same at all camps, therefore it looks veri/ viicch as if there was a milder ty'pe of disease on Sesse than on the mainland. If this is true it would explain the great difference in the death-rate observed by us in our mainland camps and that already reported by the German Commission at their former camp on Sesse. Treatment with*'Soamin {Sodinm-amino-iidienyl-arsinate ; B. JV. & Co.). Treatment with Soamin has been carried out on a small scale on Kyagwe Camp by Dr. van Someren, who strongly urges its more general use as, in his opinion, his results with it are as good as his results with Atoxyl. Dr. van Someren also lays stress on the uniformity of the different samples of this preparation and points out that its cost is only one-third of that of Atoxyl. A large consignment of Kharsin f has now been ordered so that very shortly it will receive an extensive trial. Dr. van Someren’s report on “ Soamin ” is given in detail:— Sir, I have the honour in accordance with the Principal Medical Officer’s I’equest to submit to you a report on the administration of “ Soamin ” {sodtum-amino-plienyl-arsinate, Burroughs Wellcome and Co.) in tlie tx’eatment of sleeping sickness. My first trial of this drug was in September, 1907, with some samples sent nie by Messrs. Burroughs Wellcome and Co., and though the quantity supplied was too small for a complete trial, tlie results were sufficiently encouraging to enable me to recommend a furtlier trial. I received iurther quantities from them in December, 1907, and 1 lb. from you on January 23, 1908. It is to be regretted, I think, that the supply was not sufficient for treating, say, 50 or 100 patients, from the point of view of testing for its toxicity over a large number of persons. Charaeters.—l. Samples were in Jtabloid form, fairly soluble in cold watei, more so in hot, but the solution liad a slight yellow colour and did not keep so well as that of the powder form. ^ thought might be due to some decomposition having occurred in the tabloid, they arc therefore not to he reeommended. a some confusion between substanerwhieWa ^°“eren adopted the name Kharsin for the substance which was afterwards called by Messrs. Burroughs Wellcome & Co. Soamin. [Ed.] This subsTaLf\b'et abovo-mentioned error in nomenclature, been abandS.^? ] of Soamin, proved most unsatisfactory, and its use has ” P'^obable, but not certain, that the tabloids consisted of Orsudan and not of Soamin.